Comments: NJ A1136 | 2022-2023 | Regular Session
Bill Title: Requires physician to offer to test patient for dihydropyrimidine dehydrogenase deficiency prior to patient undergoing chemotherapy.
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced - Dead) 2022-01-11 - Introduced, Referred to Assembly Health Committee [A1136 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced - Dead) 2022-01-11 - Introduced, Referred to Assembly Health Committee [A1136 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2022 New Jersey A1136 at this time. |